Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2009; 55(3): 37-43


Sirna-mediated silencing of 5-lipoxygenase gene (alox5) reduces necrosis ofcardiomyocytes in anoxia-reoxygenation

O.O. Lisovyy, V.S. Nagibin, O.V. Surova, L.v TumanovskA., V.E. Dosenko, A.A. MoibenkO.

    O.O. Bogomoletz Institute of Physiology NationalAcademy Sciences of Ukraine, Kyiv


Abstract

In experiments on the primary culture of isolated neonatal rat cardiomyocytes it was determined that cardiomyocytes express ALOX5 gene encoding enzyme 5-lipoxygenase. Anoxia-reoxy-genation does not affect significantly the expression of 5-lipoxygenase mRNA in cardiomyocytes. Transfection of 5-lipoxygenase-specific small interfering RNA’s (siRNA) into cardiomyocytes lead to a significant reduction of 5-lipoxygenase mRNA expression in cardiomyocytes 24 hours after transfec-tion. ALOX5 gene silencing resulted in improved viability of cell population (by 13,3 % P<0,001) due to decreased number of necrotic (by 14,6 %, P<0,001), but not apoptotic, cells during anoxia-reoxygenation. Our results indicate that siRNA against ALOX5 effectively protects cardiomyocytes against anoxia-reoxygenation injury.

References

  1. Досенко В.Є., Нагібін B.C., Тумановська Л.В. та ін. Посткондиціювання запобігає апоптичній, некро­тичній та аутофагічній смерті кардіоміоцитів у культурі // Фізіол. журн. - 2005. - 51. - P. 12-17.
  2. Колчин Ю.Н., Попович Л.Ф., Грабовский Л.А. и др. Влияние ингибитора 5-липоксигеназы кверцетина на морфофункциональные проявления поврежде­ния миокарда при ишемии-реперфузии сердца // Кардиология. - 1990. - 30, № 3. - С. 72-75.
  3. Пархоменко А.Н., Мойбенко А.А., Кожухов С.Н. и др. Первый опыт применения внутривенной формы ингибитора 5-липоксигеназы у больных с острым инфарктом миокарда: клинико-гемодинамические параллели, влияние препарата на размеры некроза // Укр. кардіол. журн. - 2000. - № 1-2. - C. 5-9.
  4. Тумановська Л.В., Досенко В.Є., Нагібін B.C. та in. Апоптотична, аутофагічна та онкотична смерть кардіоміоцитів при аноксії-реоксигенації // Фізіол. журн. - 2004. - 50, № 5. - P.11-18.
  5. Brash A. R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate // J. Biol. Chem. -1999. - 274. - P. 23679-23682.
  6. Carol A. Sledz, Bryan R. G. Williams. RNA interference in biology and disease // Blood. - 2005. - 106. - P. 787-794.
  7. Dosenko V.E., Nagibin V.S., Tumanovskaya L.V. et al. Proteasomal proteolysis in anoxia-reoxygenation, pre­conditioning and postconditioning of isolated cardio-myocytes // Pathophysiology. - 2006. - 2. - P. 119-125.
  8. Duvoisin R.M., K. van Leyen, Engelhardt H., Wiedmann M. A function for lipoxygenase in pro­grammed organelle degradation // Nature. - 1998. - 395. -P. 392-395.
  9. 9. Festjens N., Vanden Berghe T., Vandenabeele P. Ne­crosis, a well-orchestrated form of cell demise: Signal­ling cascades, important mediators and concomitant immune response // Biochim. and Biophys. Acta. -2006. - 1757. - P. 1371-1387.
  10. 10. Fire A., Xu S., Montgomery M.K., Kostas S. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans // Nature. -1998. – 391. - P.806 - 811.
  11. Hashimoto H., Miyazawa K., Hagiwara M. et al. Ben­eficial effects of a new 5-lipoxygenase inhibitor on occlusion- and occlusion-reperfusion-induced myocar­dial injury // Arzneimittelforschung. - 1990. - 40, №2, Pt 1. - P. 126-9.
  12. Heise C.E., O’Dowd B.F., Figueroa D.J. et al Characte­rization of the human cysteinyl leukotriene 2 receptor // J. Biol. Chem. - 2000. - 275. - P. 30531-30536.
  13. Huiwen Song., Zhiyong Zhong., Lin Wong. Small in­terference RNA against PTP-1B reduces hypoxia/re-oxygenation induced apoptosis of rat cardiomyocytes // Apoptosis. - 2008. - 13. - P. 383-393.
  14. Kamohara M., Takasaki J., Matsumoto M. et al. CysLT2 receptors on human coronary artery smooth muscle cells // Biochem. and Biophys. Res. Commun. -2001. - 287. - P. 1088-1092.
  15. Kuhn H., Belkner J., Wiesner R., Brash A.R. Oxygen­ation of biological membranes by the pure reticulocyte lipoxygenase // J. Biol. Chem. - 1990. - 265. - P. 18351-18361.
  16. Liu P., Misurski D.A., Gopalakrishnan V. Cysteinyl leukotriene-dependent [Ca] responses to angiotensin II in cardiomyocytes // Amer. J. Physiol. Heart Circulat. Physiol. - 2003. - 284. - P. 1269-1276.
  17. Lynch K.R., O’Neill G.P., Liu Q. et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor // Nature. - 1999. - 399. - P. 789-793.
  18. Maccarrone M., Melino G., Finazzi-Agro A. Lipoxy­genases and their involvement in programmed cell death // Cell Death Differ. - 2001. - 8. - P. 776-784.
  19. 19. Margaret A. Nordlie, Loren E. et al. Molecular as­pects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy // J. Cardiovasc. Pharmacol. Therap. - 2006. - 11, № 1. - P. 17-30.
  20. 20. Masahiro S., Keiko T., Tomoji H., Naoki M. RNA interference targeting SHP-1 attenuates myocardial in­farction in rats // FASEB J. - 2005. - 19, № 14. -P. 2054-2056.
  21. Murphy R. C, Gij’on M. A. Biosynthesis and me­tabolism of leukotrienes // Biochem. J. - 2007. - 405. -P. 379-395.
  22. Nakayama H., Chen X., Baines C.P. Ca2+ and mito-chondrial-dependent cardiomyocyte necrosis as a pri­mary mediator of heart failure // J. Clin. Invest. - 2007. -117, №9. - P. 2431-2444.
  23. Ogasawara H., Ishii S., Yokomizo T. et al. Charac­terization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution // J. Biol. Chem. -2002. - 277. - P. 18763-18768.
  24. Redmark O. Arachidonate 5-lipoxygenase // Prostag­landins & other Lipid Mediators. - 2002. - 68-69. -P. 211-234.
  25. Reinecke H., Zhang M., Bartosek T., Charles E.M. Survival, integration, and differentiation of cardiomyo­cyte grafts // Circulation. - 1999. - 100. - P. 193-202.
  26. Riccioni G., Capra V., D’Orazio N. et al. Leukotriene modifiers in the treatment of cardiovascular diseases // J. Leukoc. Biol. - 2008. - Sep. 15.
  27. Spiteller G. Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases? // Med. Hypoth­eses. - 2003. - 60, № 1. - P. 69-83.
  28. Zimmermann K.C., Bonzon C, Green D.R. The ma­chinery of programmed cell death // Pharmac. Thera­peutics. - 2001. - 92. - P. 57-70.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.